Hospital
River Hospital, INC.
River Hospital, INC. was paid $13.49M by Medicaid between Jan 2018 and Nov 2024, across 114 billing codes. Its largest line is 90834, psychotherapy session, about 45 minutes — 19% of everything it billed.
33Billing provider infoRIVER HOSPITAL, INC.
ALEXANDRIA BAY, NY 13607
ALEXANDRIA BAY, NY 13607
33aNPI1003814641assigned 07/08/2005
33bProvider typeCritical Access Hospital
28Total paid$13.49M
24GClaims109,985
24DCodes billed114
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in New York
Rank by total paid#4 of 12
Median peer was paid$5.23M
This provider vs. median2.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,384 | $100K | |
| 2019 | 5,951 | $319K | |
| 2020 | 19,876 | $1.16M | |
| 2021 | 22,752 | $1.54M | |
| 2022 | 22,182 | $4.78M | |
| 2023 | 23,381 | $3.89M | |
| 2024incomplete | 13,459 | $1.70M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 19% | 11,009 | 7,216 | $2.54M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 9.3% | 5,748 | 5,472 | $1.26M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 8.1% | 5,493 | 4,326 | $1.09M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 7.8% | 7,842 | 7,250 | $1.05M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 7.8% | 6,392 | 5,620 | $1.05M |
| 36415 | Collection of venous blood by venipuncture | 6.5% | 6,186 | 5,614 | $881K |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 3.8% | 1,294 | 1,014 | $506K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.4% | 2,319 | 2,119 | $465K |
| 80053 | Comprehensive metabolic panel | 3.2% | 6,648 | 6,189 | $433K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.2% | 1,354 | 1,321 | $427K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.0% | 4,823 | 1,312 | $406K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2.9% | 1,331 | 1,179 | $386K |
102 more codes
| 99284 | Emergency room visit (serious) | 2.8% | 2,883 | $376K |
| 87581 | 2.5% | 1,888 | $336K | |
| 99285 | Emergency room visit (most serious) | 1.7% | 1,865 | $232K |
| 90791 | Psychiatric diagnostic evaluation | 1.6% | 903 | $214K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.3% | 518 | $174K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.1% | 1,368 | $147K |
| 99441 | 1.1% | 336 | $146K | |
| 99214 | Doctor's office visit, returning patient (more involved) | 1.0% | 1,403 | $139K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 937 | $134K |
| 99442 | <1% | 231 | $95K | |
| 81025 | <1% | 755 | $93K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 157 | $72K |
| Q3014 | Telehealth originating site facility fee | <1% | 321 | $68K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 194 | $68K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 301 | $54K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 344 | $53K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 794 | $51K |
| 80061 | Lipid panel | <1% | 2,562 | $50K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,330 | $43K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,593 | $37K |
| 87486 | <1% | 1,890 | $36K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,701 | $34K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 856 | $34K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 414 | $33K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 107 | $17K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 58 | $16K |
| 84439 | <1% | 1,748 | $16K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,810 | $16K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 259 | $15K |
| 99000 | <1% | 600 | $13K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,552 | $12K |
| 98968 | <1% | 143 | $12K | |
| 99490 | Ccm add 20min | <1% | 118 | $11K |
| 85027 | <1% | 1,331 | $10K | |
| 99443 | <1% | 27 | $10K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 389 | $9K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 55 | $8K |
| 90847 | Family psychotherapy with the patient present, 50 minutes | <1% | 24 | $8K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,221 | $8K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 135 | $7K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 17 | $6K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | <1% | 71 | $6K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 258 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 130 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 785 | $4K |
| 98967 | <1% | 45 | $4K | |
| 90686 | <1% | 146 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 46 | $3K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 28 | $3K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 14 | $3K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 967 | $3K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 480 | $3K |
| 97162 | <1% | 25 | $3K | |
| 90715 | <1% | 40 | $3K | |
| 83735 | <1% | 1,435 | $3K | |
| Q2038 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) | <1% | 89 | $3K |
| 97161 | <1% | 25 | $2K | |
| 83540 | <1% | 418 | $2K | |
| 83550 | <1% | 392 | $2K | |
| 99499 | <1% | 12 | $2K | |
| 82607 | <1% | 122 | $2K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 20 | $2K |
| 81001 | <1% | 387 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 14 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 343 | $1K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 14 | $1K |
| 99051 | <1% | 102 | $1K | |
| 81000 | <1% | 732 | $937.94 | |
| 81002 | <1% | 629 | $926.04 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 28 | $846.25 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 31 | $773.70 |
| G0008 | Administration of influenza virus vaccine | <1% | 52 | $674.73 |
| 97010 | <1% | 30 | $581.40 | |
| 82728 | <1% | 57 | $505.45 | |
| 85610 | <1% | 374 | $448.74 | |
| 90734 | <1% | 25 | $446.25 | |
| 84484 | <1% | 341 | $382.10 | |
| 86140 | <1% | 96 | $354.96 | |
| 83690 | <1% | 880 | $354.80 | |
| 85730 | <1% | 615 | $350.30 | |
| 83605 | <1% | 190 | $294.75 | |
| 85651 | <1% | 46 | $287.78 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 211 | $256.71 |
| 84703 | <1% | 88 | $128.04 | |
| 86430 | <1% | 12 | $125.52 | |
| 82043 | <1% | 15 | $105.16 | |
| 87088 | <1% | 26 | $76.72 | |
| 90785 | <1% | 18 | $76.50 | |
| 87186 | <1% | 29 | $65.28 | |
| 73630 | <1% | 26 | $60.24 | |
| 87590 | <1% | 12 | $53.07 | |
| 94761 | <1% | 48 | $50.88 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 64 | $44.51 |
| 87490 | <1% | 12 | $38.58 | |
| 81003 | <1% | 16 | $24.88 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 70 | $1.41 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 29 | $0.03 |
| G0307 | Complete (cbc), automated (hgb, hct, rbc, wbc; without platelet count) | 0% | 40 | $0.00 |
| 71045 | Radiologic examination, chest; single view | 0% | 100 | $0.00 |
| 87070 | 0% | 14 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 29 | $0.00 |
| 80305 | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMASTALER, EMILY (CEO)